The role of the Ikaros gene in lymphocyte development and homeostasis
- PMID: 9143685
- DOI: 10.1146/annurev.immunol.15.1.155
The role of the Ikaros gene in lymphocyte development and homeostasis
Abstract
The Ikaros gene, which encodes a family of hemopoietic-specific zinc finger proteins, is described as a central regulator of lymphocyte differentiation. During fetal development, it is required at the earliest stage of T cell and B cell specification. In the adult, however, lymphoid lineages rely on Ikaros at distinct phases of their development. Its activity is essential for the generation of B cell but not of T cell precursors, although the differentiation of the latter is not normal. A significant increase in CD4 thymocytes and their immediate precursors is detected, and because these cells lack markers that correlate with positive selection, a deregulation in their maturation process is suggested. Furthermore, Ikaros-null thymocytes hyperproliferate in response to T cell receptor (TCR) signaling; within days after their appearance in the thymus, clonally expanding populations are detected. Deregulated TCR-mediated responses and the fast kinetics of tumor development in these mutant thymocytes implicate Ikaros as a central tumor suppressor gene for the T cell lineage. In addition, lack of natural killer cells and selective defects in gamma delta T cells and dendritic antigen-presenting cells point to Ikaros as an essential factor for the establishment of early branchpoints of the T cell pathway. The dominant interference activity of Ikaros isoforms unable to bind DNA and their effects in lymphocyte development suggest that Ikaros works in concert with other factors. The role of Aiolos, a lymphoid-restricted and structurally related gene, in lymphoid differentiation is discussed. A model is proposed that defines Ikaros as the backbone of a complex regulatory protein network that controls cell fate decisions and regulates homeostasis in the hemo-lymphoid system. Changes in this regulatory network may reflect differentiation and proliferation adjustments made in hemo-lymphoid progenitors and precursors as they give rise to the cells of our immune system.
Similar articles
-
Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation.EMBO J. 1997 Apr 15;16(8):2004-13. doi: 10.1093/emboj/16.8.2004. EMBO J. 1997. PMID: 9155026 Free PMC article.
-
Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development.EMBO J. 1996 Oct 1;15(19):5358-69. EMBO J. 1996. PMID: 8895580 Free PMC article.
-
Aiolos and Ikaros: regulators of lymphocyte development, homeostasis and lymphoproliferation.Apoptosis. 2002 Jun;7(3):277-84. doi: 10.1023/a:1015372322419. Apoptosis. 2002. PMID: 11997672 Review.
-
Ikaros in hemopoietic lineage determination and homeostasis.Semin Immunol. 1998 Apr;10(2):119-25. doi: 10.1006/smim.1998.0113. Semin Immunol. 1998. PMID: 9618757 Review.
-
Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.Clin Cancer Res. 1999 Aug;5(8):2112-20. Clin Cancer Res. 1999. PMID: 10473095
Cited by
-
Structure and function insights into the NuRD chromatin remodeling complex.Cell Mol Life Sci. 2015 Jul;72(13):2491-507. doi: 10.1007/s00018-015-1880-8. Epub 2015 Mar 22. Cell Mol Life Sci. 2015. PMID: 25796366 Free PMC article. Review.
-
T and B cell abnormalities, pneumocystis pneumonia, and chronic lymphocytic leukemia associated with an AIOLOS defect in patients.J Exp Med. 2021 Dec 6;218(12):e20211118. doi: 10.1084/jem.20211118. Epub 2021 Oct 25. J Exp Med. 2021. PMID: 34694366 Free PMC article.
-
A kindred with mutant IKAROS and autoimmunity.J Allergy Clin Immunol. 2018 Aug;142(2):699-702.e12. doi: 10.1016/j.jaci.2018.04.008. Epub 2018 Apr 27. J Allergy Clin Immunol. 2018. PMID: 29705243 Free PMC article.
-
Widespread intronic polyadenylation diversifies immune cell transcriptomes.Nat Commun. 2018 Apr 30;9(1):1716. doi: 10.1038/s41467-018-04112-z. Nat Commun. 2018. PMID: 29712909 Free PMC article.
-
Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?Endocr Pathol. 2021 Mar;32(1):3-16. doi: 10.1007/s12022-021-09663-4. Epub 2021 Jan 12. Endocr Pathol. 2021. PMID: 33433883 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials